References of "Krzesinski, Jean-Marie"
     in
Bookmark and Share    
Full Text
See detailPrise en charge de l'HTA résistante. Quoi de neuf en 2019?
KRZESINSKI, Jean-Marie ULiege

Conference (2019, May 12)

Detailed reference viewed: 11 (2 ULiège)
Full Text
See detailHTA réfractaire et dénervation rénale : regain d'intérêt?
KRZESINSKI, Jean-Marie ULiege; MARTINEZ, Christophe ULiege

Conference (2019, May 11)

Detailed reference viewed: 13 (2 ULiège)
Full Text
Peer Reviewed
See detailPerformance of creatinine- or cystatin C-based equations to estimate glomerular filtration rate in sub-Saharan African populations
Bukabau, JB; Yayo, E; Gnionsahé, A et al

in Kidney International (2019), 95(5), 1181-1189

Detailed reference viewed: 16 (5 ULiège)
Full Text
See detailSel je t'aime
Krzesinski, Jean-Marie ULiege

Conference (2018, October 20)

Le sel est indispensable pour plusieurs fonctions vitales mais trop engendre un risque d’HTA et un risque cardiovasculaire. •Une réduction de la quantité consommée est à imposer (de façon individuelle ... [more ▼]

Le sel est indispensable pour plusieurs fonctions vitales mais trop engendre un risque d’HTA et un risque cardiovasculaire. •Une réduction de la quantité consommée est à imposer (de façon individuelle)mais dans des limites raisonnables. •Des encouragements répétés sont indispensables. [less ▲]

Detailed reference viewed: 18 (3 ULiège)
Full Text
See detailWhat can we learn from an unrepresentative population screening for hypertension?
Saint-Remy, Annie ULiege; Moritz, Corentin ULiege; Narinx, Justine ULiege et al

Conference (2018, October 06)

WHAT CAN WE LEARN FROM A UNREPRESENTATIVE POPULATION SCREENING FOR HYPERTENSION ? A. Saint-RemyA, C. Moritz*, J. Narinx*, Ch. Van Severen*, S. Van Steenberge*, A. Wozolek* and JM. KrzesinskiA (A ... [more ▼]

WHAT CAN WE LEARN FROM A UNREPRESENTATIVE POPULATION SCREENING FOR HYPERTENSION ? A. Saint-RemyA, C. Moritz*, J. Narinx*, Ch. Van Severen*, S. Van Steenberge*, A. Wozolek* and JM. KrzesinskiA (A) Nephrology-Hypertension-Transplantation; * Medical student Uliège AIM: May Measurement Month (MMM) survey was initiated by ISH and approached more than 100 countries for contribution to improve awareness of hypertension (HT) which remains a worldwide problem. Present study reports the statistics for a belgian regional screening organized in May 2017 in the University Hospital of Liege. METHOD:468 participants (≥18 years) attended a 4 days screening, they were interviewed to collect: weight, height, antihypertensive treatment, diabetes, smoking, alcohol consumption and history of cv events. Three consecutive BP measurements were done with Omron M6. Participants received advices on how to maintain a good cv health and a card with their BP to share with their physician. Those with high BP (≥140 and/or ≥ 90 mmhg) received explanations on their readings and actions needed. We added questions on Home Blood Pressure (HBP) to assess the frequency of people who practice HBP and the importance they gave it in the management of HT by physicians. RESULTS: 91% of participants were white, mean age: 52.2±18, women: 56%, 10% had diabetes, 23% were current smokers, less than 5% had a history of heart attack or stroke. Alcohol consumption was regular in 40%. As a whole, HT was identified in 23% and 1/3 were treated. In those treated, BP was uncontrolled in 31.5%. No significant difference of cv profile was found between uncontrolled and controlled treated participants. However, the untreated HT were significantly older, had a higher BMI and a higher consumption of alcohol than untreated NT. At home,52 % had an HBP monitor and measured their BP 5 times/month on average. When treated, at least 50% being either controlled or not considered that HBP should be integrated by the physician into the management of their HT. CONCLUSION: Despite the limits of such tool to assess prevalence of HT, screening offered a great opportunity to inform people on HT and cv risks, on how correctly measure BP and on the importance of adherence to treatment. [less ▲]

Detailed reference viewed: 36 (5 ULiège)
Full Text
See detailBlood pressure and CKD : the lower the better?
Krzesinski, Jean-Marie ULiege

Conference (2018, October 06)

Management of blood pressure in adult CKD patients with and without diabètes. In HTA with CKD : individualization of the BP target! BP lowering is a critical component of preventing mortality, CKD ... [more ▼]

Management of blood pressure in adult CKD patients with and without diabètes. In HTA with CKD : individualization of the BP target! BP lowering is a critical component of preventing mortality, CKD progression and CV complications among those with CKD. Evidence supports at least a goal BP <140/90 mmHg (Level I A/B). The exception to this statement is if albuminuria is present, <130/80 mmHg can then be supported for CKD slower (Level II B). In oldest patients (>75) a BP target not lower than 140 mmHg must be proposed. ABPM should be used to test the 24h BP control . [less ▲]

Detailed reference viewed: 23 (2 ULiège)
Full Text
Peer Reviewed
See detailComment j'explore...Une protéinurie
Résimont, Guillaume ULiege; GADISSEUR, Romy ULiege; LUTTERI, Laurence ULiege et al

in Revue Médicale de Liège (2018), 73(10), 519-525

Detailed reference viewed: 35 (8 ULiège)
Peer Reviewed
See detailGenetic deletion of DUSP3 phosphatase attenuates kidney damage and inflammation following ischemia/reperfusion in mouse
Rowart, Pascal ULiege; POMA, Laurence ULiege; Rahmouni, Souad ULiege et al

Poster (2018, May 25)

Background. Renal ischemia-reperfusion (I/R) injury represents an unavoidable event in kidney transplantation. Dual Specificity Phosphatase 3 (DUSP3, also called Vaccinia-H1 Related (VHR)) is highly ... [more ▼]

Background. Renal ischemia-reperfusion (I/R) injury represents an unavoidable event in kidney transplantation. Dual Specificity Phosphatase 3 (DUSP3, also called Vaccinia-H1 Related (VHR)) is highly expressed in endothelial cells, as well as in platelets, monocytes and macrophages. Since DUSP3 is a positive regulator of the innate immune response, its inactivation/deletion may attenuate kidney inflammation and damage caused by I/R. Methods. Ten-weeks-old C57BL/6 wild-type (WT, n=10) versus systemic knock-out (KO, n=10) mice underwent unilateral left renal ischemia for 30 minutes. Right nephrectomy was simultaneously performed. The left kidney was excised and blood sample was collected from inferior vena cava at 48h post reperfusion. Renal function was assessed upon Blood Urea Nitrogen (BUN) levels. Expressions of inflammatory and immune markers were comparatively quantified at both mRNA (real-time qPCR) and protein (immune-blotting and –staining) levels in ischemic vs. non-ischemic kidneys in DUSP3 WT vs. KO mice. Results. BUN reached 259±51 vs 78±11mg/dL in WT and KO, respectively (p<0.01). DUSP3 KO ischemic kidneys showed a reduced number of PCNA- (3-fold, p<0.001), CD11b- (3.5-fold, p<0.001) and F4-80-positive cells (1.7-fold, p<0.001) in comparison to WT. The expression levels of CD11b (2.2-fold, p<0.01), HSP70 (2.7-fold, p<0.01) and PCNA (10-fold, p<0.001) were significantly decreased in DUSP3 KO compared to WT ischemic kidneys. By contrast, a 1.5-fold increase of anti-inflammatory M2 CD206-positive macrophages was observed in DUSP3 KO ischemic kidneys. At transcriptional levels, DUSP3 WT vs. KO ischemic kidneys (normalized to WT sham-operated right kidneys) showed an upregulation of 6.5-fold (p<0.05) vs. 10.5-fold (p<0.01) of M2-type macrophage (Arginase), 4.6-fold (p<0.001) vs. 2.2-fold (p<0.05) of CD11b, 4.5-fold (p<0.001) vs. 0.7-fold (p>0.05) of TNF and 111-fold (p<0.001) vs. 4.5-fold (p>0.05) of KIM-1, respectively. Conclusions. Genetic deletion of DUSP3 attenuates renal I/R-associated damage and inflammation. [less ▲]

Detailed reference viewed: 33 (13 ULiège)
Full Text
Peer Reviewed
See detailGUT MICROBIOTA AND FAECAL LEVELS OF SHORT CHAIN FATTY ACIDS DIFFER UPON BLOOD PRESSURE LEVELS IN MAN
HUART, Justine ULiege; Leenders, Justine ULiege; Taminiau, Bernard ULiege et al

in Nephrology Dialysis Transplantation (2018, May 18), 33(Issue suppl_1), 368369

Detailed reference viewed: 36 (14 ULiège)
Full Text
Peer Reviewed
See detailHyperoxalurie primaire de type 1 : de l'enfance à l'âge adulte, comment gérer adéquatement l'adhésion au traitement médical?
LEFLOT, Marie ULiege; Krzesinski, Jean-Marie ULiege; COLLARD, Laure ULiege et al

in Néphrologie et Thérapeutique (2018), 14(3), 148-152

We report the cases of three young patients suffering from type 1 primary hyperoxaluria, a metabolic genetic disorder characterized by intracellular accumulation of oxalate and which may result in ... [more ▼]

We report the cases of three young patients suffering from type 1 primary hyperoxaluria, a metabolic genetic disorder characterized by intracellular accumulation of oxalate and which may result in endstage renal disease with systemic impairment. A number of effective conservative therapeutic means are available for early management of affected children particularly when he is growing older. Despite the demonstrated efficacy of conservative therapy, compliance represents a major and daily challenge. Monitoring therapeutic compliance is thus an important task for physicians in charge of this disease. A better understanding of non-compliance causes is required to improve the follow-up of patients for whom treatment education must be a priority. [less ▲]

Detailed reference viewed: 81 (6 ULiège)
Peer Reviewed
See detailGenetic deletion of DUSP3 phosphatase attenuates kidney damage and inflammation following ischemia/reperfusion in mouse
Rowart, Pascal ULiege; POMA, Laurence ULiege; Rahmouni, Souad ULiege et al

Conference (2018, April 20)

Background. Renal ischemia-reperfusion (I/R) injury represents an unavoidable event in kidney transplantation. Dual Specificity Phosphatase 3 (DUSP3, also called Vaccinia-H1 Related (VHR)) is highly ... [more ▼]

Background. Renal ischemia-reperfusion (I/R) injury represents an unavoidable event in kidney transplantation. Dual Specificity Phosphatase 3 (DUSP3, also called Vaccinia-H1 Related (VHR)) is highly expressed in endothelial cells, as well as in platelets, monocytes and macrophages. Since DUSP3 is a positive regulator of the innate immune response, its inactivation/deletion may attenuate kidney inflammation and damage caused by I/R. Methods. Ten-weeks-old C57BL/6 wild-type (WT, n=10) versus systemic knock-out (KO, n=10) mice underwent unilateral left renal ischemia for 30 minutes. Right nephrectomy was simultaneously performed. The left kidney was excised and blood sample was collected from inferior vena cava at 48h post reperfusion. Renal function was assessed upon Blood Urea Nitrogen (BUN) levels. Expressions of inflammatory and immune markers were comparatively quantified at both mRNA (real-time qPCR) and protein (immune-blotting and –staining) levels in ischemic vs. non-ischemic kidneys in DUSP3 WT vs. KO mice. Results. BUN reached 259±51 vs 78±11mg/dL in WT and KO, respectively (p<0.01). DUSP3 KO ischemic kidneys showed a reduced number of PCNA- (3-fold, p<0.001), CD11b- (3.5-fold, p<0.001) and F4-80-positive cells (1.7-fold, p<0.001) in comparison to WT. The expression levels of CD11b (2.2-fold, p<0.01), HSP70 (2.7-fold, p<0.01) and PCNA (10-fold, p<0.001) were significantly decreased in DUSP3 KO compared to WT ischemic kidneys. By contrast, a 1.5-fold increase of anti-inflammatory M2 CD206-positive macrophages was observed in DUSP3 KO ischemic kidneys. At transcriptional levels, DUSP3 WT vs. KO ischemic kidneys (normalized to WT sham-operated right kidneys) showed an upregulation of 6.5-fold (p<0.05) vs. 10.5-fold (p<0.01) of M2-type macrophage (Arginase), 4.6-fold (p<0.001) vs. 2.2-fold (p<0.05) of CD11b, 4.5-fold (p<0.001) vs. 0.7-fold (p>0.05) of TNF and 111-fold (p<0.001) vs. 4.5-fold (p>0.05) of KIM-1, respectively. Conclusions. Genetic deletion of DUSP3 attenuates renal I/R-associated damage and inflammation. [less ▲]

Detailed reference viewed: 33 (8 ULiège)
Peer Reviewed
See detailGenetic deletion of DUSP3 phosphatase attenuates kidney damage and inflammation following ischemia/reperfusion in mouse
Rowart, Pascal ULiege; POMA, Laurence ULiege; Rahmouni, Souad ULiege et al

Conference (2018, March 16)

Background. Renal ischemia-reperfusion (I/R) injury represents an unavoidable event in kidney transplantation. Dual Specificity Phosphatase 3 (DUSP3, also called Vaccinia-H1 Related (VHR)) is highly ... [more ▼]

Background. Renal ischemia-reperfusion (I/R) injury represents an unavoidable event in kidney transplantation. Dual Specificity Phosphatase 3 (DUSP3, also called Vaccinia-H1 Related (VHR)) is highly expressed in endothelial cells, as well as in platelets, monocytes and macrophages. Since DUSP3 is a positive regulator of the innate immune response, its inactivation/deletion may attenuate kidney inflammation and damage caused by I/R. Methods. Ten-weeks-old C57BL/6 wild-type (WT, n=10) versus systemic knock-out (KO, n=10) mice underwent unilateral left renal ischemia for 30 minutes. Right nephrectomy was simultaneously performed. The left kidney was excised and blood sample was collected from inferior vena cava at 48h post reperfusion. Renal function was assessed upon Blood Urea Nitrogen (BUN) levels. Expressions of inflammatory and immune markers were comparatively quantified at both mRNA (real-time qPCR) and protein (immune-blotting and –staining) levels in ischemic vs. non-ischemic kidneys in DUSP3 WT vs. KO mice. Results. BUN reached 259±51 vs 78±11mg/dL in WT and KO, respectively (p<0.01). DUSP3 KO ischemic kidneys showed a reduced number of PCNA- (3-fold, p<0.001), CD11b- (3.5-fold, p<0.001) and F4-80-positive cells (1.7-fold, p<0.001) in comparison to WT. The expression levels of CD11b (2.2-fold, p<0.01), HSP70 (2.7-fold, p<0.01) and PCNA (10-fold, p<0.001) were significantly decreased in DUSP3 KO compared to WT ischemic kidneys. By contrast, a 1.5-fold increase of anti-inflammatory M2 CD206-positive macrophages was observed in DUSP3 KO ischemic kidneys. At transcriptional levels, DUSP3 WT vs. KO ischemic kidneys (normalized to WT sham-operated right kidneys) showed an upregulation of 6.5-fold (p<0.05) vs. 10.5-fold (p<0.01) of M2-type macrophage (Arginase), 4.6-fold (p<0.001) vs. 2.2-fold (p<0.05) of CD11b, 4.5-fold (p<0.001) vs. 0.7-fold (p>0.05) of TNF and 111-fold (p<0.001) vs. 4.5-fold (p>0.05) of KIM-1, respectively. Conclusions. Genetic deletion of DUSP3 attenuates renal I/R-associated damage and inflammation. [less ▲]

Detailed reference viewed: 38 (14 ULiège)
Full Text
See detailHypertension artérielle et AVC
Krzesinski, Jean-Marie ULiege

Conference (2018, March 05)

Epidémiologie de la relation entre HTA et AVC. HTA et risque d'AVC primaire. HTA et récidive d'AVC. Que faire avec la PA en phase aiguë d'un AVC?

Detailed reference viewed: 54 (8 ULiège)
Full Text
See detailTraitement non pharmacologique de l'hypertension artérielle en 2018
Krzesinski, Jean-Marie ULiege

Scientific conference (2018, January 27)

Detailed reference viewed: 72 (2 ULiège)
Full Text
See detailActualités en HTA pendant l'année 2017
XHIGNESSE, Patricia ULiege; Krzesinski, Jean-Marie ULiege

Conference (2018, January 09)

Detailed reference viewed: 31 (0 ULiège)
Full Text
Peer Reviewed
See detailLa myostatine et l’IGF1 sont de bons biomarqueurs de la force musculaire chez les patients hémodialysés chroniques
Bataille, Stanislas; QUINONEZ, Kevin ULiege; Buckinx, Fanny ULiege et al

in Néphrologie et Thérapeutique (2018), 14(5), -4

Detailed reference viewed: 21 (3 ULiège)
Full Text
Peer Reviewed
See detailHand grip strength measurement in haemodialysis patients: before or after the session?
DELANAYE, Pierre ULiege; QUINONEZ, Kevin ULiege; Buckinx, Fanny ULiege et al

in Clinical Kidney Journal (2018), 11(4), 555-558

Detailed reference viewed: 22 (3 ULiège)